Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2025-12-25 @ 3:46 AM
NCT ID:
NCT00317902
Eligibility Criteria:
Inclusion Criteria:
* Understand and sign written informed consent
* HIV-infected patients (as documented by HIV-RNA values)
* HIV/HCV co-infected patients not receiving treatment
* Hemoglobin \< 12 g/dL unrelated to transfusion
* Estimated life expectancy of \> 9 months
* Has been maintained on a stable antiretroviral regimen for at least four weeks prior to enrollment into this study.
Exclusion Criteria:
* Acute, symptomatic opportunistic infection or other acute AIDS defining illness
* Anemia attributable to factors other than HIV infection (i.e., iron, B12 or folate deficiencies, hemolysis, gastrointestinal bleeding)
* HCV co-infected patients who are anticipated to receive treatment with ribavirin/interferon during the study period. Previous treatment with ribavirin/interferon must have been completed at least 12 weeks prior to study entry
* Ferritin level \< 40 ng/mL
* Uncontrolled or severe cardiovascular disease including recent (\< 6 months) myocardial infarction, uncontrolled hypertension or congestive heart failure
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00317902
Study Brief:
Protocol Section:
NCT00317902